Safety and Performance of a New Coating for Urinary Intermittent Catheters

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intermittent Urethral Catheterization Clinical Trial

Official title:
Clinical Study Investigating Safety and Performance of a New Coating for Urinary Intermittent Catheters in Healthy Volunteers

Status Completed

Clinical Trial Summary

The aim of the study is to evaluate safety and performance of a new catheter coating,compared to the current SpeediCath coating.

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT02911051` - Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients	N/A
Completed	`NCT04033913` - What Are the Criteria for the Patient's Choice of Sel-catheterization Catheter
Active, not recruiting	`NCT04763382` - The Effect of Nursing Interventions for Clean Intermittent Catheterization Caregivers and Child	N/A
Completed	`NCT02129738` - Reuse of Intermittent Urethral Catheters	N/A
Completed	`NCT04095871` - Determinants, Impact and Adherence Related to the Duration of Performing Self Catheterization on Patient Satisfaction and Quality of Life
Completed	`NCT03684941` - Evaluation of a New Catheter Coating Process for Urinary Catheters Used for Intermittent Catheterization.	N/A